Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group

Sluis, I.M. van der; Groot-Kruseman, H. de; Loo, M. te; Tissing, W.J.E.; Bos, C. van den; Kaspers, G.J.L.; ... ; Pieters, R. (2018)

Article / Letter to editor

• efficacy
• pediatric acute lymphoblastic leukemia
• randomized trial
• recombinant asparaginase
• toxicity

• All authors: Sluis, I.M. van der; Groot-Kruseman, H. de; Loo, M. te; Tissing, W.J.E.; Bos, C. van den; Kaspers, G.J.L.; Bierings, M.; Kollen, W.J.W.; Konig, T.; Pichlmeier, U.; Kuhnel, H.J.; Pieters, R.
• Date: 2018-08-31
• Journal: Pediatric Blood & Cancer
• Volume: 65
• Issue: 8
• DOI: doi:10.1002/pbc.27083